Overall prognosis of acute and chronic musculoskeletal, widespread, and neuropathic pain in children and adolescents

Laura R.C. Montgomery, Steven J. Kamper*, Zoe A. Michaleff, Christopher M. Williams, Amabile Dario, Paul Campbell, Alessandro Andreucci, Daniëlle A.W.M. van der Windt, Kate M. Dunn, Michael S. Swain

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Objectives: This is a protocol for a Cochrane Review (prognosis). The objectives are as follows:. We aim to describe the overall prognosis (focusing on the pain course) and the negative impact(s) of acute and chronic musculoskeletal, widespread, and neuropathic pain in children (aged six to 12 years) and adolescents (aged 13 to 18 years) by evaluating:. incidence of pain recovery at three and 12 months after reporting acute or chronic pain; change in pain severity at three and 12 months after reporting acute or chronic pain; and negative impact(s) of pain at three and 12 months after reporting chronic pain.

Original languageEnglish
Article numberCD014773
JournalCochrane Database of Systematic Reviews
Volume2023
Issue number2
DOIs
Publication statusPublished - 27 Feb 2023
Externally publishedYes

Fingerprint

Dive into the research topics of 'Overall prognosis of acute and chronic musculoskeletal, widespread, and neuropathic pain in children and adolescents'. Together they form a unique fingerprint.

Cite this